© 2003 BMJ Publishing Group Ltd
LETTER TO JMG
A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations
1 Collagen Research Unit, Biocentre and Department of Medical Biochemistry and Molecular Biology, University of Oulu, Oulu, Finland
2 Division of Paediatric Neurology, University Childrens Hospital, Zurich, Switzerland
3 Division of Molecular Paediatrics, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
4 Paediatric Practice, Mollis, Switzerland
5 University Childrens Hospital, Leipzig, Germany
6 Division of Radiology, University Childrens Hospital, Zurich, Switzerland
7 Division of Paediatric Radiology, Kantonspital, Aarau, Switzerland
8 Center for Gene Therapy and Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
Correspondence to:
Correspondence to:
Professor A Superti-Furga
Division of Molecular Paediatrics, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland; asuperti@chuv.unil.ch
Keywords: cartilage oligomeric matrix protein; collagen IX; multiple epiphyseal dysplasia
Abbreviations: CSGE, conformation sensitive gel electrophoresis; MED, multiple epiphyseal dysplasia; PSACH, pseudoachondroplasia
| The first 150 words of the full text of this article appear below. |
Multiple epiphyseal dysplasia (MED) is clinically and genetically a heterogeneous disorder that affects growth centres and results in delayed and irregular mineralisation of the ossification centres.1,2 Recessively inherited MED (rMED; MIM 226900) accounts for a significant proportion of MED cases and is associated with mutations in the sulphate transporter gene, DTDST/SLC26A2.3,4 More often, MED is inherited as a dominant trait. Thus far, five different genes have been implicated in dominantly inherited MED: the gene for cartilage oligomeric matrix protein, COMP (MIM 600310); the genes for the
1,
2, and
3 chains of collagen IX, COL9A1 (MIM 120165), COL9A2 (MIM 120260), and COL9A3 (MIM 120270); and the gene for matrilin-3, MATN3 (MIM 602109). Patients with the severe forms of MED have short stature and major disability because of joint pain and stiffness. In the milder forms, height can be normal and joint complaints minimal.
Mutations in COMP typically lead to the
This article has been cited by other articles:
-
Merritt, T. M., Bick, R., Poindexter, B. J., Alcorn, J. L., Hecht, J. T.
(2007). Unique Matrix Structure in the Rough Endoplasmic Reticulum Cisternae of Pseudoachondroplasia Chondrocytes. Am. J. Pathol.
170: 293-300
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Another family with multiple epiphyseal dysplasia harboring the R718W mutation in COMP
- Shiro Ikegawa, et al.
- J Med Genet, 25 Jun 2004 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
